[1] 侯大为,郭建清,岳海泉,等.牙周炎与高脂血症的相关性研究[J].口腔医学研究,2018,34(11):1192-1195. [2] Zhang J, Yu C, Zhang X, et al. Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL/6 mice [J]. J Neuroinflammation, 2018, 15(1): 37. [3] Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation [J]. Nat Rev Immunol, 2015, 15(1):30-44. [4] BoseDasgupta S, Pieters J. Macrophage-microbe interaction: lessons learned from the pathogen Mycobacterium tuberculosis [J]. Semin Immunopathol, 2018, 40:577-591. [5] Weng Z, Chi Y, Xie J, et al. Anti-inflammatory activity of dehydroandrographolide by TLR4/NF-kappaB signaling pathway inhibition in bile duct-ligated mice [J]. Cell Physiol Biochem, 2018, 49:1083-1096. [6] Fujita M, Kuraji R, Ito H, et al. Histological effects and pharmacokinetics of lipopolysaccharide derived from Porphyromonas gingivalis on rat maxilla and liver concerning with progression into non-alcoholic steatohepatitis [J]. J Periodontol, 2018, 89(9):1101-1111. [7] Pockpa ZA, Struillou X, Coulibaly NT, et al. Potential relationship between periodontal diseases and eye diseases [J]. Med Hypotheses, 2017, 99: 63-66. [8] Alakhali MS, Al-Maweri SA, Al-Shamiri HM, et al. The potential association between periodontitis and non-alcoholic fatty liver disease: a systematic review [J]. Clin Oral Investig, 2018, 22:2965-2974. [9] Olsen I, Yilmaz Ö. Modulation of inflammasome activity by Porphyromonas gingivalis in periodontitis and associated systemic diseases [J]. J Oral Microbiol, 2016, 8(1):30385. |